Ocular Therapeutix, Inc. (OCUL) financial statements (2021 and earlier)

Company profile

Business Address 24 CROSBY DRIVE
BEDFORD, MA 01730
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2285454426810575
Cash and cash equivalents228545442333137
Short-term investments    357437
Receivables12300000
Inventory, net of allowances, customer advances and progress billings1100000
Inventory1100000
Deferred costs   0   
Other undisclosed current assets5221121
Total current assets:2466056437010776
Noncurrent Assets
Operating lease, right-of-use asset67
Property, plant and equipment8101010332
Restricted cash and investments2272200
Total noncurrent assets:16191712532
TOTAL ASSETS:2627973557511078
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities171198756
Accounts payable3334221
Accrued liabilities14864533
Employee-related liabilities      1
Debt81 62 1
Deferred revenue and credits  00
Other undisclosed current liabilities1     (1)
Total current liabilities:2712913856
Noncurrent Liabilities
Long-term debt and lease obligation49582512141514
Long-term debt, excluding current maturities41492512141514
Operating lease, liability89
Liabilities, other than long-term debt1101233100
Deferred revenue and credits33100
Deferred revenue12 
Derivative instruments and hedges, liabilities9812     
Total noncurrent liabilities:159702816151514
Total liabilities:186823729232119
Stockholders' equity
Stockholders' equity attributable to parent76(4)3626529059
Common stock0000000
Additional paid in capital615380333263226219148
Accumulated other comprehensive loss    (0)(0) 
Accumulated deficit(539)(384)(297)(237)(174)(129)(89)
Total stockholders' equity:76(4)3626529059
TOTAL LIABILITIES AND EQUITY:2627973557511078

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues17422221
Revenue, net2221
Cost of revenue(2)(2)(0)(0)(0)(0)(0)
Cost of goods and services sold(2)(2) (0)(0)(0)(0)
Gross profit:15221111
Operating expenses(78)(88)(61)(63)(45)(40)(28)
Other undisclosed operating income     00
Operating loss:(63)(86)(59)(62)(43)(38)(27)
Nonoperating expense(93)(1)(1)(1)(1)(2)(2)
Investment income, nonoperating0110000
Other nonoperating income (expense) (0) 0(0)0(0)
Interest and debt expense(7)(6)(2)(2)(2)(2)(1)
Loss before gain (loss) on sale of properties:(162)(92)(62)(65)(46)(41)(30)
Other undisclosed net income71792    
Net income (loss):(156)86(60)(65)(46)(41)(30)
Other undisclosed net income (loss) attributable to parent (173) 2221
Net loss attributable to parent:(156)(86)(60)(63)(45)(40)(29)
Preferred stock dividends and other adjustments      (0)
Net loss available to common stockholders, diluted:(156)(86)(60)(63)(45)(40)(29)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(156)86(60)(65)(46)(41)(30)
Comprehensive income (loss):(156)86(60)(65)(46)(41)(30)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (173) 222 
Comprehensive loss, net of tax, attributable to parent:(156)(86)(60)(63)(45)(40)(30)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: